You are viewing the site in preview mode
Skip to main content
|
Characteristics
| |
|---|
|
OAT sequences
| |
|
Patients with 1 sequence
|
92.8%
|
|
Patients with 2 sequences
|
6.4%
|
|
Patients with 3 sequences
|
0.7%
|
|
Patients with 4 sequences
|
0.08%
|
|
Sex (%)
| |
|
Male
|
75.0%
|
|
Female
|
25.0%
|
|
Age when treatment started
| |
|
< 20
|
4.8%
|
|
20–24
|
25.7%
|
|
25–29
|
27.9%
|
|
30–39
|
27.2%
|
|
> 39
|
14.4%
|
|
Region
| |
|
Vienna
|
28%
|
|
Other Austrian federal states
|
72%
|
|
Substitution medication
|
Start of sequence
|
End of sequence
|
|---|
|
Methadone
|
23.2%
|
20.5%
|
|
Levo-methadone
|
6.9%
|
8.4%
|
|
Buprenorphine
|
25.9%
|
24.3%
|
|
Buprenorphine/naloxone
|
5.7%
|
5.0%
|
|
Slow-release morphine
|
36.2%
|
39.9%
|
|
Other
|
1.1%
|
1.4%
|
|
Unknown
|
1.0%
|
0.5%
|
